Research Article

A Cell Component-Related Prognostic Signature for Head and Neck Squamous Cell Carcinoma Based on the Tumor Microenvironment

Figure 5

Crossplatform analysis and expression of immune checkpoint genes TCGA cohort. (a–c) Boxplots showed that the low-risk group presented with lower copy number variation (CNV), aneuploidy score, and tumor purity (). (d) Heatmap presented with differential expression of immune checkpoint genes in TCGA cohort. Numerous immune checkpoint genes were significantly higher in the low-risk group ( and an adjusted value < 0.05, “LRisk-UP” in the annotation on the right means that the expressions of these genes are upregulated in the low-risk group, and “No-Sig” means that there is no statistical difference between these two groups).
(a)
(b)
(c)
(d)